NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Richard Dean Braatz · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · 2022 · $500,000 — Project Summary: A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic response This proposal aims to design, develop, and manufacture a virus-like particle (VLP) vaccine for SARS-CoV-2, and the techniques developed throughout the work can be applied to accel…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Surojit Sarkar · SEATTLE CHILDREN'S HOSPITAL · 2022 · $166,916 — ABSTRACT (COVID-19 SUPPLEMENTAL RESEARCH) During fast-spreading disease outbreaks (such as the present COVID-19 pandemic), quick induction of herd immunity through vaccination is critical. Currently there are many SARS-CoV2 candidate vaccines in various stages of clinical development, aimed at indu…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Peter B. Gilbert · FRED HUTCHINSON CANCER CENTER · 2022 · $318,803 — Project Abstract This proposal outlines the scientific agenda for the COVID-19 Prevention Network (CoVPN) Vaccines Leadership Operations Center (LOC) for implementation of the first COVID-19 vaccine efficacy trial “A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults …
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Margaret Juliana McElrath · FRED HUTCHINSON CANCER CENTER · 2022 · $3,544,100 — FOA: PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements Activity Code/Award: UM1/A1068614-15 (parent award) ------------------------------------------------------------------------------------ Project Abstract This proposal outlines the scientific agenda for the …
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Margaret Juliana McElrath · FRED HUTCHINSON CANCER CENTER · 2022 · $531,957 — This proposal outlines the scientific agenda for the COVID-19 Prevention Network (CoVPN) Vaccines Leadership Operations Center (LOC) for implementation of the first COVID-19 vaccine efficacy trial “A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the …
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Peter B. Gilbert · FRED HUTCHINSON CANCER CENTER · 2022 · $419,442 — Project Abstract This proposal outlines the scientific agenda for the COVID-19 Prevention Network (CoVPN) Vaccines Leadership Operations Center (LOC) for implementation of the COVID-19 vaccine efficacy trial entitled “A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Neil King · UNIVERSITY OF WASHINGTON · 2022 · $9,065,441 — PROJECT SUMMARY – OVERALL: Structure-based design of broadly protective coronavirus vaccines We propose a highly synergistic research Program focused on developing two broadly protective coronavirus vaccine candidates: a pan-sarbecovirus vaccine at the end of Year 2, and a pan-betacoronavirus at the…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Yingjie Chen · PURDUE UNIVERSITY · 2022 · $122,453 — Project Summary Cryo-electron microscopy (cryoEM) revolutionized structural biology, providing a powerful method to study biological specimens in their native environment. However, a major bottleneck hindering the wider use of cryoEM is the lack of trained professionals capable of proficiently opera…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Chao Wang · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · 2022 · $229,011 — Project Summary/Abstract As of mid June 2021, the new coronavirus disease (COVID-19), caused by SARS-CoV-2 virus, has infected ~180 million people and causing ~3.8 million deaths globally. There are more than 34 million confirmed cases and ~620,000 deaths in the U.S alone. The fast transmission, as…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Wonpil Im · LEHIGH UNIVERSITY · 2022 · $226,313 — PROJECT SUMMARY/ABSTRACT The current pandemic of Coronavirus Disease-2019 (COVID-19) has had devastating impacts across the world. In order to enter human host cells, SARS-CoV-2, the virus causing COVID-19, uses its surface spike (S) protein to attach to host cell surface receptors. Besides the best…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Bing Chen · BOSTON CHILDREN'S HOSPITAL · 2022 · $816,144 — Project Summary The first critical step for enveloped viruses, such as HIV-1, to enter host cells is viral membrane fusion. Viral fusion proteins are fascinating protein folding machineries capable of adopting completely different conformations during the fusion process; they are also important vac…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
AMIN S GHABRIAL · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2022 · $335,807 — Ghabrial – Project Summary To build a functional vascular system, a network of endothelial tubes must be generated through a combination of vasculogenesis and angiogenesis. During sprouting angiogenesis, endothelial tip cells lead the outgrowth of new branches. Tip cells anastomose with other tip ce…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Ya-Wen Chen · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · 2022 · $705,521 — Project Summary In early 2020, a new virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), generated headlines due to its unprecedented rate of transmission. SARS-CoV-2 caused the first reported cases of coronavirus disease 2019 (COVID-19) in December 2019 and continues to spread wor…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
DAVID BAKER · UNIVERSITY OF WASHINGTON · 2022 · $713,861 — PROJECT SUMMARY One of the most pressing public health priorities for the COVID-19 pandemic is the development of an effective and inexpensive therapeutic. The long-term goal of this proposal is to develop such COVID-19 treatments, as well as the methods needed to rapidly create such molecules as so…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
TRACEY MCLAUGHLIN · STANFORD UNIVERSITY · 2022 · $196,750 — PROJECT SUMMARY/ABSTRACT Obesity is a major risk factor for severe outcomes in Covid-19, exceeding the risk associated with type 2 diabetes and hypertension by 3-fold. The underlying reason is unknown. While obese individuals may have an impaired immune response or a predilection towards inflammatio…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Lin Gan · AUGUSTA UNIVERSITY · 2022 · $231,000 — PROJECT SUMMARY / ABSTRACT Taste deficits are prevalent in people infected with SARS-CoV-2, the virus responsible for the global COVID-19 pandemic. The loss of taste sensation negatively affects nutrition and quality of life and in some patients this deficit is long-lasting. The biological basis for…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
YUICHIRO Justin SUZUKI · GEORGETOWN UNIVERSITY · 2022 · $70,304 — Summary/Abstract Currently the world is suffering from the pandemics of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that uses angiotensin-converting enzyme 2 (ACE2) as a receptor to enter host cells. So far, over five million people ha…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Patrizia Farci · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · 2022 · $47,717 — Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants The RNA nature and broad circulation of SARS-CoV-2 enable the accumulation of mutations leading to the continuous emergence of variants with increased transmissibility or pathogenicity as well as resistance to…
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
Mario Borgnia · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · 2022 · $376,946 — We have established high-throughput structure determination workflows using single particle analysis cryo-EM (SPA) on variants of the SARS-CoV-2 S protein ectodomain. These workflows allow us to solve the structure of macromolecular complexes of the spike at near atomic resolution with less than 24 …
NIH Pandemic-Era Grants
· Pandemic Era Grants
/ 2022
H. Clifford Lane · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · 2022 · $138,903 — Research in this project is currently focused on six areas. These are: characterization of the survivors of the anthrax attacks of 2001; characterization of emerging respiratory infections including SARS, COVID-19, and influenza; evaluation of experimental vaccines and treatments for Ebola virus; c…